Latest Revenue Recognition News

Within six weeks of commissioning, Aguia Resources has secured over A$2.3 million in sales of its Pampafos organic phosphate fertiliser, marking a key transition to revenue-generating operations with deliveries scheduled through year-end.

GR Engineering Services confirms ongoing work on Tower Hill Gold Project but notes processing shift to King of the Hills plant following Genesis Minerals' acquisition of Vault Minerals.

Visionflex Group turned the corner with positive operating cash flow in Q4 FY26 and the launch of its unattended access capability, while securing new contracts to expand its virtual healthcare footprint.

Cogstate Ltd smashed previous records with $89 million in net sales contracts for FY26, more than doubling the prior year. The company enters FY27 with a robust $118.5 million revenue backlog, signalling solid growth visibility.

8common's subsidiary Expense8 has landed a significant three-year contract with the Australian Taxation Office worth $1.95 million, expanding its reach within the Commonwealth Government and enhancing recurring revenue visibility.

AdNeo's Aspire by Catapult has won a $187,546 contract to develop human rights eLearning courses for Queensland's public sector, marking a second engagement with the Queensland Human Rights Commission. The company's tender pipeline now exceeds $6 million, signalling ongoing growth opportunities.

Compumedics reported a record $60.3 million in FY26 revenue, driven by an 18% year-on-year increase and a 70% jump in SaaS recurring revenues from Somfit and Nexus 360. The company resolved supply chain disruptions and targets faster EBITDA growth in FY27.

SRJ Technologies has started delivering services under two major Middle East contracts, marking the transition from agreements to revenue-generating operations with AD Ports Group’s Divetech and Dubai Petroleum.

Algorae Pharmaceuticals has clinched a multi-year public hospital supply contract with NSW Health, marking a significant commercial milestone. The rollout is set to begin in the fourth quarter of 2026, underpinning the company's growth ambitions in the Australian healthcare market.

Memphasys has locked in a three-year exclusive distribution agreement for its Felix™ sperm separation system in Thailand, targeting a key IVF market with 110 clinics and 20,000–30,000 cycles annually. The deal adds approximately A$430,500 in contracted revenue, lifting South-East Asian minimum contracts to about A$1 million and contributing to FY2026 Felix™ sales now exceeding A$3 million.

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.

TruScreen Group posted a NZ$2.25 million loss for FY2026, with its auditor highlighting material uncertainty over the company’s ability to continue without further funding. Revenue rose to NZ$2.4 million amid geographic expansion, but cash burn and accumulated losses remain significant.